Plasma Amyloid Beta Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment: The BALTAZAR Study
(1)
,
(2, 3)
,
(4, 5)
,
(6, 7)
,
(8)
,
,
(9, 10, 11, 12)
,
(13)
,
,
(14)
,
,
(15)
,
(16, 17, 18, 19)
,
(20)
,
(21, 22)
,
(23, 24, 25)
,
(26)
,
(27, 28)
,
(29)
,
(30, 31)
,
(32)
,
(33)
,
(34)
,
(35, 36, 37)
,
,
(38, 39)
,
(32, 40)
,
(41)
,
(42)
,
(43)
,
(44, 45)
,
(2, 46)
,
(16)
,
(47)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
Christiane Baret-Rose
- Fonction : Auteur
Patrick Gelé
- Fonction : Auteur
Frédéric Blanc
- Fonction : Auteur
- PersonId : 1115317
- IdHAL : fredericblanc
Philippe Robert
- Fonction : Auteur
Olivier Godefroy
- Fonction : Auteur
- PersonId : 901333
- ORCID : 0000-0001-6789-6620
- IdRef : 068994737
Jean-Luc Novella
- Fonction : Auteur
- PersonId : 752799
- IdHAL : jean-luc-novella
- ORCID : 0000-0002-7074-7500
- IdRef : 059281316
Résumé
INTRODUCTION: Blood-based biomarkers are the next challenge for Alzheimer's disease (AD) diagnosis and prognosis. METHODS: Mild cognitive impairment (MCI) participants (N = 485) of the BALTAZAR study, a large-scale longitudinal multicenter cohort, were followed-up for 3 years. A total of 165 of them converted to dementia (95% AD). Associations of conversion and plasma amyloid beta (Aβ)1-42 , Aβ1-40 , Aβ1-42 /Aβ1-40 ratio were analyzed with logistic and Cox models. RESULTS: Converters to dementia had lower level of plasma Aβ1-42 (37.1 pg/mL [12.5] vs. 39.2 [11.1] , P value = .03) and lower Aβ1-42 /Aβ1-40 ratio than non-converters (0.148 [0.125] vs. 0.154 [0.076], P value = .02). MCI participants in the highest quartile of Aβ1-42 /Aβ1-40 ratio (>0.169) had a significant lower risk of conversion (hazard ratio adjusted for age, sex, education, apolipoprotein E \epsilon4, hippocampus atrophy = 0.52 (95% confidence interval [0.31-0.86], P value = .01). DISCUSSION: In this large cohort of MCI subjects we identified a threshold for plasma Aβ1-42 /Aβ1-40 ratio that may detect patients with a low risk of conversion to dementia within 3 years.